{"name": "LiPlasome Pharma",
 "permalink": "liplasome-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/liplasome-pharma",
 "homepage_url": "http://www.liplasome.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "45-72-15-15-00",
 "description": "",
 "created_at": "Sat Jul 03 13:41:50 UTC 2010",
 "updated_at": "Sat Jul 03 13:51:12 UTC 2010",
 "overview": "\u003Cp\u003ELiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the market like Cispaltin -\u0026gt; LiPlaCis\u00c2\u00ae, Oxaliplatin -\u0026gt; LiPloxa.\nThe aim is to provide more effective treatment to cancer patients with fewer side effects.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       55],
      "assets/images/resized/0009/2370/92370v1-max-150x150.jpg"],
     [[214,
       79],
      "assets/images/resized/0009/2370/92370v1-max-250x250.jpg"],
     [[214,
       79],
      "assets/images/resized/0009/2370/92370v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8.01M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 8010000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 3,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Incuba Venture",
         "permalink": "incuba-venture",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BankInvest Biomedical Venture",
         "permalink": "bankinvest-biomedical-venture",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0005/0286/50286v1-max-150x150.png"],
             [[150,
               19],
              "assets/images/resized/0005/0286/50286v1-max-250x250.png"],
             [[150,
               19],
              "assets/images/resized/0005/0286/50286v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vecata",
         "permalink": "vecata",
         "image":
          {"available_sizes":
            [[[150,
               15],
              "assets/images/resized/0004/9936/49936v4-max-150x150.png"],
             [[250,
               25],
              "assets/images/resized/0004/9936/49936v4-max-250x250.png"],
             [[339,
               34],
              "assets/images/resized/0004/9936/49936v4-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Dandyvej 19",
    "address2": "",
    "zip_code": "DK-7100",
    "city": "Vejle",
    "state_code": null,
    "country_code": "DNK",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        108],
       "assets/images/resized/0009/2371/92371v1-max-150x150.jpg"],
      [[250,
        181],
       "assets/images/resized/0009/2371/92371v1-max-250x250.jpg"],
      [[450,
        326],
       "assets/images/resized/0009/2371/92371v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}